Phase II Clinical Trial of Purified Isoflavones in Prostate Cancer: Comparing Safety, Effectiveness

Completed · Phase 2 · Has a placebo group

Conditions studied: Prostate Cancer

In brief

The purpose of our study is to recruit and treat 96 men diagnosed with prostate cancer and scheduled for a prostatectomy with a capsule form of either purified isoflavones or placebo for a 3-6 week period to see if we can slow down the rate of prostate cancer growth. A placebo is a pill or something that looks like the medicine that is being studied but has no active medicine in it. We also want to see if taking purified isoflavones is safe and if it reduces lower urinary tract symptoms. In addition, we want to study if purified isoflavones are able to slow the progression of prostate cancer, and the mechanism of action of purified isoflavones. If the safety and the effects of purified isoflavones on slowing down the progression of prostate cancer is shown in our study, this will also be a safe way of treating men who are at high risk of prostate cancer, so that we can prevent prostate cancer in the future.

Key facts

Study ID: NCT01036321
Run by: H. Lee Moffitt Cancer Center and Research Institute
People needed: 71
Starts: 2009-12-11
Expected to finish: 2018-04-16
Last updated by the study team: 2019-08-06

Who can join

Age: 30 and older, up to 80. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

Diagnosis of localized prostate cancer (PCa), based on pathological assessment from biopsy specimens
No prior or current therapy for PCa or history of cancer except non-melanoma skin cancer
Scheduled for prostatectomy between 3- 6 weeks (+/-3 days) after start of study agent
No known history of hepatic or renal disease (LFTs (SGOT/SGPT) > 5.0 x upper limit of normal as evidenced by impairment of baseline laboratory values, Actual creatinine clearance of >60 utilizing the Cockcroft-Gault formula (1976), which employs creatinine measurements and a patient's weight to predict the clearance. The constant is 1.23 for men.
Omnivorous diet
No evidence of prostatitis or urinary tract infection
Able and willing to give written informed consent
Currently not using or willing to discontinue any nutritional supplements that contain soy or soy isoflavones
Not allergic to study supplements
Not on antibiotics
Men who do not consume more than 3 - 4 oz. of soy or soy products per week
Not taking steroid hormones or medications which have known impact on prostatic specific antigen (PSA)
Health status cleared by primary MD or urologist
Eastern Cooperative Oncology Group (ECOG) performance status of 0-1

You may not qualify if…

Prior history of prostate cancer; Current or prior history of other malignancies (exceptions include nonmelanoma skin cancer or other cancer with no evidence of tumor recurrence five years after definitive treatment)
History of renal or hepatic disease, including history of hepatitis B, C or delta as evidenced by impairment of baseline laboratory values
Participation in any other investigational study or use of any other investigational agents within 30 days of study entry
History of allergic reactions attributed to soy isoflavones or other compounds of similar chemical or biologic composition to Novasoy 400® or the inactive components present in the purified isoflavone and placebo capsules
Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or any psychological, familial, sociological or other concomitant condition that would not allow adequate compliance with the study protocol
Only African American (a person having origins in any of the black racial groups of Africa) and Caucasian (a person having origins in any of the original people of Europe, Middle East, or North Africa) men, as defined by the NIH, will be included in this study. Since this is an investigation targeting men with PCa, women are not eligible for the study.

Where it is running

University of Florida & Shands Medical Center - Jacksonville — Jacksonville, Florida, United States
H. Lee Moffitt Cancer Center and Research Institute — Tampa, Florida, United States
James A. Haley VA Hospital — Tampa, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.